ArticleThe Ulster medical journal2019

Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.

R R McMullan et al.PubMed ↗Full text ↗

No numbers read from the abstract.